Wołowiec, Ł.; Kusiak, M.; Budzyński, J.; Wołowiec, A.; Jaśniak, A.; Wiciński, M.; Pedrycz-Wieczorska, A.; Rogowicz, D.; Grześk, G.
Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study. J. Clin. Med. 2023, 12, 4969.
https://doi.org/10.3390/jcm12154969
AMA Style
Wołowiec Ł, Kusiak M, Budzyński J, Wołowiec A, Jaśniak A, Wiciński M, Pedrycz-Wieczorska A, Rogowicz D, Grześk G.
Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study. Journal of Clinical Medicine. 2023; 12(15):4969.
https://doi.org/10.3390/jcm12154969
Chicago/Turabian Style
Wołowiec, Łukasz, Mateusz Kusiak, Jacek Budzyński, Anna Wołowiec, Albert Jaśniak, Michał Wiciński, Agnieszka Pedrycz-Wieczorska, Daniel Rogowicz, and Grzegorz Grześk.
2023. "Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study" Journal of Clinical Medicine 12, no. 15: 4969.
https://doi.org/10.3390/jcm12154969
APA Style
Wołowiec, Ł., Kusiak, M., Budzyński, J., Wołowiec, A., Jaśniak, A., Wiciński, M., Pedrycz-Wieczorska, A., Rogowicz, D., & Grześk, G.
(2023). Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study. Journal of Clinical Medicine, 12(15), 4969.
https://doi.org/10.3390/jcm12154969
